Clinical trial
Pharmacokinetic Study in Cerebral Spinal Fluid After a Single Dose of AVI-4020
NCT00387283 · Sarepta Therapeutics, Inc., Industry · Completed
Key facts
| NCT number | NCT00387283 |
|---|---|
| Title | Pharmacokinetic Study in Cerebral Spinal Fluid After a Single Dose of AVI-4020 |
| Official title | Pharmacokinetic Study of AVI-4020 in Cerebral Spinal Fluid Among Healthy Adult Males Following Intravenous Administration |
| Lead sponsor | Sarepta Therapeutics, Inc., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | West Nile Virus |
| Intervention type | Drug |
| Interventions | AVI-4020 Injection |
| Enrollment | 14 |
| Start date | Oct 1, 2006 |
| Primary completion | Dec 1, 2006 |
| Completion | Jun 1, 2009 |
| First posted | Oct 13, 2006 |
| Last update posted | Jul 8, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: